Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-19-013779

Options or other derivatives

  • Director acquired 357 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HILL DAVID LOUIS Director 2019-03-12 Grant or award · Share Option (Right to Buy) +357 357 D
Loading xslF345X03/tv516188_4.xml…